4:15 pm Immunogen announces first clinical findings with refined dosing strategy for IMGN853: Initial Findings Show New Dosing Approach for IMGN853 Achieves Objective – HedgeChatter

4:15 pm Immunogen announces first clinical findings with refined dosing strategy for IMGN853: Initial Findings Show New Dosing Approach for IMGN853 Achieves Objective

09 Apr

4:15 pm Immunogen announces first clinical findings with refined dosing strategy for IMGN853: Initial Findings Show New Dosing Approach for IMGN853 Achieves Objective

Bystocknews IMGN, stock Comments Off

View todays social media effects on IMGN

View the latest stocks trending across Twitter. Click to view dashboard

See who ImmunoGen is hiring next, click here to view

Author